Free Newsletter
1918 flu survivors' blood may hold key to better vax
Scientists were able to identify the antibodies that still circulate in the blood of survivors of the deadly 1918 flu outbreak and found that they still proved to be a potent antidote to the disease. There's no threat of a new outbreak of that particular flu virus, but the research provides solid proof that the human immune system has an incredibly powerful memory once it learns to fight off a disease.
Not only did the antibodies survive, they mutated and became even more powerful. And using the same techniques could make new vaccines for a current lineup of bird flus much more effective.
"The Lord has blessed us with antibodies our whole lifetime," said study co-author Dr. Eric Altschuler at the University of Medicine and Dentistry in New Jersey. "What doesn't kill you, makes you stronger."
--read the AP story
Related Articles:
GSK bird flu vaccine wins race for European OK
Universal flu vaccine shows early promise
Breakthrough reported in flu vaccine research
Emergent BioSolutions buys flu vaccine maker
Comments
By rdc123 | Posted 1:40pm | August 21, 2008
I think that's a wonderful story, my mom was a child born in 1918. I didn't get an opportunity to ask before she died, but I'm sure her mother would have remembered that time.
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: